Antigen introduction typically involves injecting an antigen into a mouse so that its lymphocytes begin producing a targeted antibody. This step ensures the immune system generates the specific antibody needed for later cloning.
Lymphocyte extraction occurs once antibody production begins, at which point spleen cells are harvested because they contain many activated lymphocytes. This maximises the chances of isolating the desired antibody-producing cell.
Cell fusion uses chemicals or electrical stimulation to merge lymphocytes and tumour cells into hybridomas, which possess both antibody‑producing ability and rapid division capability. This fusion is essential because neither cell type alone can meet the production requirements.
Hybridoma selection is performed using a selective medium in which only successfully fused cells can survive, ensuring a pure population of hybridomas. This step prevents unfused tumour or lymphocyte cells from contaminating the line.
Cloning hybridomas involves isolating single hybridoma cells and allowing them to divide repeatedly, generating identical cell populations. Each clone produces one unique antibody, making selection of the best‑performing clone possible.
Antibody harvesting and purification occur once hybridomas produce enough antibodies, usually by growing them in cell culture and extracting the antibodies from the liquid medium. Purification ensures the final product is suitable for medical or scientific use.
| Feature | Lymphocytes | Tumour Cells | Hybridoma Cells |
|---|---|---|---|
| Function | Produce specific antibodies | Divide rapidly | Produce antibodies and divide indefinitely |
| Lifespan | Short-lived | Long-lived | Long-lived |
| Use in Production | Provides specificity | Provides immortality | Used for mass production |
Natural antibodies vs monoclonal antibodies differ in consistency because natural immune responses generate a mixture of different antibodies, whereas monoclonal antibodies are identical. This distinction is crucial when predictable, high‑specificity behaviour is needed.
Polyclonal vs monoclonal production differs in the uniformity of antibodies produced; polyclonal methods rely on many lymphocytes and yield variable antibodies, while monoclonal methods guarantee identical binding sites. This affects accuracy in research and diagnostics.
Always emphasise specificity when explaining monoclonal antibody functions, because exam questions often test understanding that each antibody binds to one antigen. Clearly linking specificity to applications demonstrates deeper reasoning.
Describe the hybridoma process sequentially, as many exam questions assess understanding of the order of steps. Articulating the sequence shows conceptual clarity rather than memorisation.
Check for common distractors, such as confusing lymphocytes with white blood cells in general or assuming tumour cells make antibodies. Ensuring correct terminology helps avoid losing marks.
Explain why each step is necessary, not just what happens, because examiners reward mechanistic understanding. Linking each stage to its biological purpose strengthens answers.
Thinking tumour cells produce antibodies is a common misconception, but in reality, they only provide the ability to divide indefinitely. Recognising this distinction clarifies why cell fusion is essential.
Mixing up polyclonal and monoclonal antibodies can lead to confusion about specificity, since polyclonal mixtures vary in their binding and are unsuitable for precise targeting. Understanding this helps students justify the need for monoclonal approaches.
Believing all antibodies are identical ignores natural immune diversity, where many lymphocytes produce slightly different antibodies. Monoclonality is an engineered exception created for controlled use.
Assuming hybridomas arise naturally is incorrect; they only form through laboratory fusion processes. Clarifying this helps students understand the technological aspect of the method.
Links to immunology are strong because monoclonal antibody production depends on the adaptive immune system’s specificity and memory. Understanding these foundations helps explain how antibodies recognise antigens.
Applications in diagnostics and therapeutics stem directly from the predictability of monoclonal antibodies, which allows precise detection of molecules or targeted delivery of drugs. This connection explains why they revolutionised multiple medical fields.
Relevance to biotechnology arises because hybridoma formation, cell culture, and purification require standard biotechnological techniques. Mastery of these processes opens pathways to advanced applications like biosensors and personalised medicine.
Ethical considerations emerge from using animals in antibody production and from concerns about treatment side effects. Recognising these issues promotes more informed decision‑making.
